1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with pentoxifylline in 17 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (pentoxifylline) | Trials (pentoxifylline) | Recent Studies (post-2010) (pentoxifylline) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 4,437 | 657 | 943 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | pentoxifylline (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Homo sapiens (human) | 6.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 9 (52.94) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adi, S; Feingold, KR; Fiers, W; Grunfeld, C; Moser, A; Soued, M | 1 |
| Freyburger, G; Hammerschmidt, DE; Huh, PW; Kotasek, D; McCarthy, T; Vercellotti, GM | 1 |
| Bodlaj, R; Glaubitt, SI; Hübner, C; Krombach, F; Lehr, HA; Messmer, K; Münzing, S; Seiffge, D; von Andrian, UH | 1 |
| Adams, JG; Dhar, A; Shukla, SD; Silver, D | 1 |
| Chen, SF; Ding, ZQ; Fei, X; Li, SH; Wu, ZL | 1 |
| Bell, M; Hellstrom, WJ; Sikka, SC; Wang, R | 1 |
| Bell, M; Hellstrom, WJ; Sikka, SC; Veeraragavan, K; Wang, R | 1 |
| Bernard, GR; Weikert, LF | 1 |
| Lee, DR; Lee, JE; Roh, SI; Yoon, HS | 1 |
| Basile, AS; Kustova, Y; Markey, SP; Morse, HC; Nishida, K; Sei, Y | 1 |
| Gearing, A; Gendelman, HE; Limoges, J; Persidsky, Y; Rasmussen, J; Zheng, J | 1 |
| Evanson, OA; Weiss, DJ | 1 |
| Bancalari, E; Huang, J; Rodriguez, MM; Smalling, WE; Suguihara, C | 1 |
| Gilger, M; Harpavat, S; Pammi, M | 1 |
| Archer, SL; Roudebush, WE | 1 |
| Mehta, A; Sigman, M | 1 |
| Aktuna, S; Baltacı, A; Baltacı, V; Batırbaygil, H; Bereketoglu, G; Canillioglu, Y; Hurdag, C; Karayalcin, R; Ozcan, S; Turan, V; Unsal, E | 1 |
3 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pentoxifylline
| Article | Year |
|---|---|
Pharmacotherapy of sepsis.
Topics: Acetylcysteine; Antioxidants; Bradykinin; Cyclooxygenase Inhibitors; Humans; Naloxone; Pentoxifylline; Platelet Activating Factor; Sepsis | 1996 |
Novel treatments for NEC: keeping IBD in mind.
Topics: Enterocolitis, Necrotizing; Glucocorticoids; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intestinal Mucosa; Pentoxifylline; Phosphodiesterase Inhibitors; Platelet Activating Factor | 2012 |
Identification and preparation of sperm for ART.
Topics: Aneuploidy; Bicarbonates; DNA Damage; Humans; Male; Pentoxifylline; Platelet Activating Factor; Reproductive Techniques, Assisted; Safety; Sperm Motility; Sperm-Ovum Interactions; Spermatozoa | 2014 |
14 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pentoxifylline
| Article | Year |
|---|---|
Search for mediators of the lipogenic effects of tumor necrosis factor: potential role for interleukin 6.
Topics: Animals; Aspirin; Azepines; Cholesterol; Fatty Acids; Ibuprofen; Interleukin-6; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Oleic Acid; Oleic Acids; Pentoxifylline; Phenoxybenzamine; Platelet Activating Factor; Propranolol; Rats; Rats, Inbred Strains; Reference Values; Triazoles; Triglycerides; Tumor Necrosis Factor-alpha | 1990 |
Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.
Topics: Blood Platelets; Cell Adhesion; Cell Aggregation; Chemotaxis, Leukocyte; Endothelium, Vascular; Granulocytes; Humans; Pentoxifylline; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation; Superoxides; Theobromine; Theophylline; Thrombin | 1988 |
In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation.
Topics: 1-Butanol; Adult; Animals; Butanols; CD18 Antigens; Cell Adhesion Molecules; Cells, Cultured; Cricetinae; Female; Flow Cytometry; Fluorescence Polarization; Humans; L-Selectin; Lipoproteins, LDL; Macrophage-1 Antigen; Male; Mesocricetus; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentoxifylline; Platelet Activating Factor; Tetradecanoylphorbol Acetate | 1995 |
Effect of pentoxifylline on tissue injury and platelet-activating factor production during ischemia-reperfusion injury.
Topics: Animals; Blood Pressure; Dogs; Female; Heart Rate; Infusions, Intravenous; Models, Cardiovascular; Muscle, Skeletal; Necrosis; Organ Size; Pentoxifylline; Platelet Activating Factor; Reperfusion Injury; Time Factors | 1995 |
Pentoxifylline attenuates platelet activating factor-induced permeable edema in isolated perfused guinea pig lungs.
Topics: Animals; Capillary Permeability; Female; Guinea Pigs; In Vitro Techniques; Lung; Male; Organ Size; Pentoxifylline; Platelet Activating Factor; Pulmonary Edema | 1994 |
Post-thaw sperm motility, cAMP concentration and membrane lipid peroxidation after stimulation with pentoxifylline and platelet-activating factor.
Topics: Adult; Cell Membrane; Cryopreservation; Cyclic AMP; Humans; In Vitro Techniques; Lipid Peroxidation; Male; Pentoxifylline; Platelet Activating Factor; Semen Preservation; Sperm Motility; Spermatozoa | 1994 |
Platelet activating factor and pentoxifylline as human sperm cryoprotectants.
Topics: Cell Survival; Cryoprotective Agents; Cyclic AMP; Freezing; Humans; Male; Pentoxifylline; Platelet Activating Factor; Reference Values; Sperm Motility; Spermatozoa | 1993 |
Induction of acrosome reaction in human spermatozoa accelerates the time of pronucleus formation of hamster oocytes after intracytoplasmic sperm injection.
Topics: Acrosome; Animals; Cricetinae; Cytoplasm; Female; Follicular Fluid; Humans; Male; Microinjections; Micromanipulation; Oocytes; Pentoxifylline; Platelet Activating Factor; Prospective Studies; Reproductive Techniques; Sperm-Ovum Interactions; Spermatozoa; Time Factors | 1997 |
Pentoxifylline decreases brain levels of platelet activating factor in murine AIDS.
Topics: Animals; Brain; Brain Diseases; Leukemia Virus, Murine; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Pentoxifylline; Phosphodiesterase Inhibitors; Platelet Activating Factor; Retroviridae Infections; Tumor Necrosis Factor-alpha; Tumor Virus Infections | 1997 |
Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis.
Topics: AIDS Dementia Complex; Animals; Benzyl Compounds; Cell Survival; Dexamethasone; Disease Models, Animal; Drug Combinations; Gliosis; HIV-1; Humans; In Vitro Techniques; Interleukin-1; Interleukin-8; Leucine; Macrophages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, SCID; Microglia; Neurons; Pentoxifylline; Platelet Activating Factor; Protease Inhibitors; Succinates; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2001 |
Evaluation of lipopolysaccharide-induced activation of equine neutrophils.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Azepines; CD11 Antigens; CD18 Antigens; Cell Degranulation; Complement System Proteins; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Flow Cytometry; Horses; Interleukin-8; Lipopolysaccharides; Neutrophil Activation; Neutrophils; Pentoxifylline; Platelet Activating Factor; Platelet Aggregation Inhibitors; Triazoles; Tumor Necrosis Factor-alpha | 2002 |
Protective effect of pentoxifylline on volume-induced lung injury in newborn piglets.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Biomechanical Phenomena; Inflammation; Lung; Lung Diseases; Lung Injury; Pentoxifylline; Peroxidase; Placebos; Platelet Activating Factor; Respiration, Artificial; Swine; Thromboxane B2; Tidal Volume | 2004 |
Enhancement of sperm motility using pentoxifylline and platelet-activating factor.
Topics: Humans; Male; Pentoxifylline; Platelet Activating Factor; Sperm Motility; Spermatozoa | 2013 |
Effects of pentoxifylline and platelet activating factor on sperm DNA damage.
Topics: Adult; DNA Damage; Humans; In Vitro Techniques; Male; Middle Aged; Pentoxifylline; Phosphodiesterase Inhibitors; Platelet Activating Factor; Sperm Motility; Spermatozoa; Young Adult | 2016 |